CTNNB1 Antikörper
(3 Referenzen)Kurzübersicht für CTNNB1 Antikörper (ABIN2717140)
Target
Alle CTNNB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Isotyp
- IgG1
-
-
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (N-Term) antibody
KO Validated CTNNB1 Reaktivität: Human WB, IHC, IF, FACS, IHC (p), IP, ICC, IHC (fro), ChIP, CUT&RUN, IHC (wm) Wirt: Kaninchen Polyclonal unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (AA 692-721), (C-Term) antibodyCTNNB1 Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB41124 unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (N-Term) antibodyCTNNB1 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (AA 2-781) antibodyCTNNB1 Reaktivität: Human WB, IHC, ELISA, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (AA 78-106), (N-Term) antibodyCTNNB1 Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB41155 unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) antibodyKO Validated CTNNB1 Reaktivität: Human WB, IHC, IF, FACS Wirt: Maus Monoclonal unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) antibodyKO Validated CTNNB1 Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Monoclonal unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (AA 1-100) antibodyCTNNB1 Reaktivität: Human, Maus WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 7C5A2 unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (AA 632-781) antibodyCTNNB1 Reaktivität: Human, Maus, Ratte, Affe WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 5B6E9 unconjugated
anti-Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1) (AA 682-781) antibodyCTNNB1 Reaktivität: Human WB, ELISA, IF, PLA, RNAi Wirt: Maus Monoclonal 1C9 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
-
-
: "Juxtaglomerular cell tumor: Clinical and immunohistochemical features." in: Journal of clinical hypertension (Greenwich, Conn.), Vol. 19, Issue 8, pp. 807-812, (2018) (PubMed).
: "PURE ANDROGEN-PRODUCING ADRENAL TUMOR: CLINICAL FEATURES AND PATHOGENESIS." in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, Vol. 23, Issue 4, pp. 399-407, (2017) (PubMed).
: "A Novel Phenotype of Familial Hyperaldosteronism Type III: Concurrence of Aldosteronism and Cushing's Syndrome." in: The Journal of clinical endocrinology and metabolism, Vol. 101, Issue 11, pp. 4290-4297, (2016) (PubMed).
-
: "Juxtaglomerular cell tumor: Clinical and immunohistochemical features." in: Journal of clinical hypertension (Greenwich, Conn.), Vol. 19, Issue 8, pp. 807-812, (2018) (PubMed).
-
- CTNNB1 (Catenin (Cadherin-Associated Protein), beta 1, 88kDa (CTNNB1))
-
Andere Bezeichnung
- Catenin beta-1
-
Pathways
- WNT Signalweg, Intracellular Steroid Hormone Receptor Signaling Pathway, Peptide Hormone Metabolism, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Tube Formation, Maintenance of Protein Location, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-
